Trials Starting With "C"

CACAF: Catheter Ablation for the Cure of Atrial Fibrillation Study

      -Trial Overview by Dr. Emanuele Bertaglia (ACC 2005)

CADILLAC: Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications Trial

      -Trial Overview

      -Abciximab & Bare Metal Stending in STEMI

      -CADILLAC Trial vs. ADMIRAL Trial

      -CADILLAC 6 Months by Dr. Gregg Stone

CAMELOT: Comparison of Amlodipine vs. Enalapril to Limit Occurrences of Thrombosis

      -CAMELOT/NORMALISE Review by Dr. Steven Nissen

CANPAP: Continuous Positive Airway Pressure for Heart Failure Patients with Central Sleep Apnea

      -Trial Overview by Dr. Douglas Bradley (ACC 2005)

CAPITAL AMI: Combined Angiopalsty and Pharmacological Intervention Versus Thrombolytics Alone in Acute Myocardial Infarction Trial

      -Trial Overview by Dr. Michel R. Le May (ACC 2004)

CAPTIM: Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction

      -One-Year Results (AHA 2002)

CAPTURE: C7E3 Fab Anti-Platelet Therapy in Unstable Refractory Angina

      -Trial Overview

Cardiac memory distinguishes between new and old left bundle branch block:

      -Cardiac memory distinguishes between new and old left bundle branch block by Dr. Alexei Shvilkin

CARE: Cardiac Angiography in REnally impaired patients

      -A Comparison Between Iodixanol (Visipaque) and Iopamidol (Isovue) in High-Risk Patients for Contrast Induced Nephropathy

CARE: Cholesterol And Recurrent Events Trial

      -The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels by Dr. Frank Sacks (1996)

CARE-HF: Cardiac Resynchronization Heart Failure Study

      -Trial Overview by Dr. John G. Cleland (ACC 2005)

CARISMA: Cardiac Arrhythmias and Risk Stratification after Myocardial Infarction

      -Long-term Cardiac Arrhythmias Recorded by Insertable Loop Recorders in Patients with Depressed Left Ventricular Function after Acute Myocardial Infarction by Dr. PE Block Thomsen

CARRESS-HF: Cardiorenal Rescue Study in Decompensated Heart Failure

      -Trial Results by Dr. Bradley Bart (AHA 2012)

CathPCI Registry:

      -Absence of Flow-Limiting Coronary Artery Disease Among Patients Undergoing Emergent Cardiac Catheterization for ST Segment Elevation Myocardal Infarction in the National Cardiovascular Data Registry CathPCI Registry: Implications for Primary Angioplasty Programs by Dr. Kalon KL Ho

      -The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report From the American College of Cardiology-National Cardiovascular Data Registry by Dr. Sunil Rao

CEREA-DES: Cortisone Plus BMS or DES versus BMS Alone to Eliminate Restenosis

      -A Prospective Randomzied Trial of Corticosteroids in Patients Undergoing Stent Implantation by Dr. Flavio Ribichini (TCT 2009)

CHAMP: Cardiac Hospitalization Atherosclerosis Management Program

      -Rationale and Design of CHAMP by Dr. Gregg Fonarow and Dr. Anna Gawlinski

 

CHARISMA: Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance

      -Trial Overview by Dr. Deepak L. Bhatt (ACC 2006)

      -Trial Overview by Dr. Eric J. Topol (2006) Portuguese

      -Data Interpretation

      -CHARISMA: The "CAPRIE-like" Cohort by Dr. Deepak L. Bhatt

      -Genomics Substudy Results by Dr. Deepak L. Bhatt

CHARM: Candesartan Cilexitil [Atacand™] in Heart Failure Assessment of Reduction Mortality and Morbidity

      -Candesartan in Heart Failure European Society of Cardiology 2003

      -Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank

 

CHILL MI: Hypothermia in Awake STEMI Patients

      -Insights and Results from RAPID MI-ICE Trial by Dr. Goran Olivecrona (C3 Complex Intervention Meeting 2011)

CIBIS III: Cardiac Insufficiency Bisoprolol Study III

      -Trial Overview by Dr. Ronnie Willenheimer (European Society of Cariology 2005)

 

CICERO: Intracoronary Versus Intravenous Abciximab in ST-Elevation Myocardial Infarction

      -Trial Results in Patients Undergoing Primary Percutaneous Coronary Intervention with Thrombus Aspiration by Dr. Youlan L. Gu (AHA 2010)

 

CILON-T: Randomized Prospective Trial of Dual vs. Triple Antiplatelet Therapy After DES Implantation

      -Trial Overview by Dr. Hyo-Soo Kim (ACC 2010)

      -Trial Overview by Dr. Hyo-Soo Kim (CRT 2011)

 

CLARIDI: Cholesterol Lowering and Arrhythmias Recurrences after Internal Defibrillator Implantation Trial

      -Trial Overview by Dr. Johan De Sutter (Heart Rhythm Society Meeting 2006)

CLARITY - TIMI 28: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction 28

      -Trial Overview

      -Trial results

CLASSICS: Clopidogrel [Plavix™] Aspirin Stent International Cooperative Study

      -Trial Overview

CLEAR PLATELETS IB Study: Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets-IB

      -A Mechanistic Link Between High Platelet Reactivity, Inflammation Marker Release and Myonecrosis in Patients Undergoing Stenting: CLEAR PLATELETS Ib STudy

CLEAR PLATELETS-2: Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets-2

      -Bivalirudin With and Without Eptifibatide for Elective Stenting: A Pharmacodynamic Study of Platelet Reactivity in Relation to the Occurrence of Periprocedural Myocardial Infarction by Dr. Paul A. Gurbel

 

Clopidogrel Platelet Reactivity Over Time in Patients Treated with PCI: Relationship with Gene Polymorphisms and Clinical Outcome

      -Overview by Gianluca Campo (CTR 2011)

 

Clopidogrel and Omeprazole Interaction Studies: Proton Pump Inhibitor Studies

      -Overview by Dr. Dominick Angiolillo

 

CLOSURE I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients with a Stroke or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale

      -Trial Overview by Dr. Anthony Furlan (AHA 2010)

CLOVIS-2: A Crossover Study of a High vs. Low Clopidogrel Loading Dose in Clopidogrel Resistant Patients
      -A Prospective, Randomized, Nested Case-Control Crossover Study of a High vs. Low Clopidogrel Loading Dose in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele by Dr. Jean-Philippe Collet (TCT 2010)

COBRA: A Prospective, Randomized Trial of Cryoplasty vs. Conventional Balloon Post-dilation of Nitinol Stents in the Superficial Femoral Artery of Patients with Diabetes Mellitus
      -Trial Overview by Dr. Subhash Banerjee (TCT 2011)

COCTAIL:
Optimal Treatment of Intracoronary Thrombosis with Local Abciximab Infusion Through the Clearway System

      -Trial Overview by Dr. Francesco Prati (TCT 2009)

      -Trial Overview by Dr. Francesco Prati (TCT 2010)

COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel

      -Results by Dr. Deepak L. Bhatt (TCT 2009)

COMET: Carvedilol or Metoprolol European Trial

      -Trial Overview European Heart Failure Meeting 2003

COMMIT/CCS-2: Clopidogrel and Metoprolol in Myocardial Infarction Trial

      -Perspective on COMMIT/CCS-2 Trial of Metoprolol in STEMI by Dr. Christopher Cannon (ACC 2005)

      -Trial Overview - Clopidogrel

      -Trial Overview - Metoprolol

 

COMPARE: Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease

     -Two-Year Results by Dr. Peter Smits

 

COMPARE-AMI: Two-Year Outcomes from a Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with STEMI

     -Two-Year Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with STEMI by Dr. Elvin Kedhi (TCT 2010)

 

Comparison of the Short-Term Survival Benefit Associated with Revascularization Compared with Medical Therapy in Patients with No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography

      -Comparison of the Short-Term Survival Benefit Associated with Revascularization Compared with Medical Therapy in Patients with No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography by Dr. Rory Hachamovitch

 

Comparison of EVEREST II High Surgical Risk and Continued Access High Surgical Risk Patient Cohorts

      -1-Year Preliminary Results by Dr. Michael Rinaldi (C3 Complex Intervention Meeting 2011)

COMPASS - HF: Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure

      -Trial Overview by Dr. Robert C. Bourge (ACC 2005)

 

Composition of Coronary Thrombus in Acute Myocardial Infarction:

      -Trial Overview by Dr. Johanne Silvain

 

CONNECT: The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial

      -The Value of Remote Monitoring by Dr. George H. Crossley (ACC 2010)

 

CONSENSUS I: Coorperative North Scandinavian Enalapril Survival Study

      -Trial Overview

CONTRAST: Contrast Media Nephrotoxicity Following Coronary Revascularization by Angioplasty

      -Randomized Clinical Trial to Compare the Nephrotoxic Effects of Iso-Osmolar vs. Low-Osmolar Contrast Medium in Patients with Impaired Renal Function Undergoing PCI European Society of Cardiology 2003

Contrast Induced Nephropathy: Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy

      -A Meta-Analysis of Published Clinical Trials by Dr. Vijayalakshmi Kunadian, Dr. Azfar Zaman, and Dr. Weiliang Qiu

 

COPPS: COlchicine for Post-Pericardiotomy Syndrome (COPPS) and Post-Operative Atrial Fibrillation (POAF) Prevention Study

      -Trial Overview by Dr. Massimo Imazio (AHA 2011)

COOL RCN: Cooling to Prevent Radiocontrast Nephropathy

      -A Prospective, Randomized Trial Examining the Safety and Efficacy of Systemic Hypothermia for the Prevention of Radiocontrast Nephropathy by Dr. Gregg W. Stone (TCT 2008)

CORONA: Controlled Rosuvastatin Multinational Trial in Heart Failure

      -Trial Overview by Dr. Ake Hjalmarson (AHA 2007)

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study

      -Trial Overview by Dr. Andre Lamy (ACC 2012)

Couma-Gen Study: Randomized Trial of Genotype-guided versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation

      -A Randomized Trial of Genotype-guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation by JL Anderson, MD (AHA 2007)

COURAGE: Clinical Outcomes Utilizing Revascularization And Aggressive Guideline-Driven Drug Evaluation

      -Trial Overview

      -Trial Overview by William E. Boden Spanish

      -Economic Results of the COURAGE Trial by Dr. William S. Weintraub

      -Trial Overview

      -Angioplasty: A Reality Check! What Does Evidence Based Medicine Tell Us? by Dr. Duane S. Pinto

      -Outcomes by Dr. William E. Boden

COURAGE Trial Nuclear Substudy: Clinical Outcomes Utilizing Revascularization & Aggressive Guideline-Driven Drug Evaluation Nuclear Substudy

      -The "Truth and Consequences" of Objective Ischemia: The COURAGE Trial Nuclear Substudy

CPORT-E: Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery

      -Trial Overview by Dr. Thomas R. Aversano (ACC 2012)

CREATE-ECLA: The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation - Estudios Cardiológicos Latinoamérica

      -Impact of Low-Molecular-Weight Heparin (Reviparin) on Mortality, Reinfarction, and Stroke in Patients with Acute MI by Dr. S.D. Yusuf (AHA 2004)

      -9-month Angiographic an 12-month Clinical Results by Dr. Yaling Han (ACC 2008)

CREATE: The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation

      -Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients with Coronary Artery Disease

CREATE-ECLA: The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation - Estudios Cardiológicos Latinoamérica

      -Impact of Low-Molecular-Weight Heparin (Reviparin) on Mortality, Reinfarction, and Stroke in Patients with Acute MI by Dr. S.D. Yusuf (AHA 2004)

      -9-month Angiographic an 12-month Clinical Results by Dr. Yaling Han (ACC 2008)

CREATE-ECLA-GIK : The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation - Estudios Cardiológicos Latinoamérica - Glucose-Insulin-Potassium

      -No Improvement in 30-day Mortality with High-Dose Glucose-Insulin-Potassium (GIK) Infusion

CREDO: Clopidogrel for the Reduction of Events During Observation

      -Final Results

 

CRISP AMI: Intra-aortic Balloon Counterpulsation and Infarct Size in Patients with Acute Interior Myocardial Infarction Without Shock

       -Trial Overview by Dr. Magnus Ohman and Dr. Manesh Patel (ESC 2011)

 

CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents

      -Trial Overview by Dr. Bernard R. Chevalier (TCT 2010)

 

CRT-D Effectiveness by QRS Duration and Morphology in the MADIT-CRT Patients:

       -Trial Overview by Dr. Wojciech Zareba

 

CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines

      -Registry Overview

      -Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes

      -Program Overview

      -A CRUSADE to Improve Quality of Care for ACS Patients by Dr. Eric D. Peterson

      -Management of Patients with NSTE ACS Latest Insights from CRUSADE by Dr. Eric D. Peterson (ACC 2005)

      -What Have We Learned from the CRUSADE Registry? by Dr. Eric D. Peterson

      -The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results from CRUSADE by Dr. Bimal R. Shah

      -CRUSADE Overview 2004

      -2006 CRUSADE 2nd Quarter Results

      -MAINTAIN CRUSADE: Medication Applied and Sustained Over Time A Longitudinal Follow-Up Study of the CRUSADE Quality Improvement Initiative

      -CRUSADE/ACTION Update by Dr. Eric D. Peterson (ACC 2006)

      -Results from the CRUSADE Quality Improvement Initiative Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease

      -Results from the CRUSADE Quality Improvement Initiative Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes

 

CRYSTAL AMI: Intracoronary Site-Specific Abciximab Compared to Intravenous Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasy

       -A Prospective Randomized Trial of Intracoronary Site-Specific Abciximab Compared to Intravenous Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasy by Dr. Rajesh M. Dav (TCT 2010)

       -Pilot Trial Results by Dr. Saihari Sadanandan (C3 Complex Intervention Meeting 2011)

 

C-SIRIUS: The Canadian Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions

      -Trial Overview

CURE: Clopidogrel in Unstable Angina to Prevent Recurrent Events

      -Trial Overview

      -Primary Outcome Stratified by TIMI Risk Score

 

CURE Genetic Substudy: Effects of CYP2C19 Genotypes on Clopidogrel Treatment in the CURE and ACTIVE Trials

      -Trial Overview by Dr. Guillaume Pare (ESC 2010)

CURRENT OASIS-7: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent Events/Optimal Antiplatelet Strategy for Interventions

      -A 2x2 Factorial Randomized Trial of Optimal Clopidogrel and Aspirin Dosing in Patients with ACS Undergoing an Early Invasive Strategy with Intent for PCI by Dr. Shamir R. Mehta

CYPHER Stent Fracture: An Uncommon Complication after "Ultra" Complex PCI

      -CYPHER Stent Fracture: An Uncommon Complication after "Ultra" Complex PCI by Dr. Jeffrey J. Popma

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster